Search
Add filters:
Use filters to refine the search results.
Item hits:
Issue Date | Title | Author(s) |
---|---|---|
2006 | Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase | Borrell Pagès, Maria; Canals i Coll, Josep M.; Cordelières, Fabrice P.; Parker, J. Alex; Pineda Martí, José Ramón; Grange, Ghislaine; Bryson, Elzbieta A.; Guillermier, Martine; Hirsch, Etienne; Hantraye, Philippe; Cheetham, Michael E.; Néri, Christian; Alberch i Vié, Jordi, 1959-; Brouillet, Emmanuel; Saudou, Frédéric; Humbert, Sandrine |
1-Sep-2015 | Decreased glycogen synthase kinase-3 levels and activity contribute to Huntington's disease | Fernández-Nogales, Marta; Hernández, Félix; Miguez, Andrés; Alberch i Vié, Jordi, 1959-; Ginés Padrós, Silvia; Pérez Navarro, Esther; Lucas, José J. |
2011 | Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction | Giralt Torroella, Albert; Carreton, Olga; Lao-Peregrin, Cristina; Martín, Eduardo D.; Alberch i Vié, Jordi, 1959- |
28-May-2020 | Deficits in coordinated neuronal activity and network topology are striatal hallmarks in Huntington's disease. | Fernández García, Sara; Orlandi, Javier G.; García-Díaz Barriga, Gerardo; Rodríguez Allué, Manuel José; Masana Nadal, Mercè; Soriano i Fradera, Jordi; Alberch i Vié, Jordi, 1959- |
1-Aug-2019 | Cyclin-Dependent Kinase 5 Dysfunction Contributes to Depressive-like Behaviors in Huntington's Disease by Altering the DARPP-32 Phosphorylation Status in the Nucleus Accumbens | Brito, Verónica; Giralt Torroella, Albert; Masana Nadal, Mercè; Royes, Aida; Espina, Marc; Sieiro, Esther; Alberch i Vié, Jordi, 1959-; Castañé, Anna; Girault, Jean-Antoine; Ginés Padrós, Silvia |
15-Feb-2012 | Don’t Take Away My P: Phosphatases as Therapeutic Targets in Huntington’s Disease | Saavedra, Ana; Alberch i Vié, Jordi, 1959-; Pérez Navarro, Esther |
18-Apr-2013 | Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies | Brito, Verónica; Puigdellívol Cañadell, Maria del Mar; Giralt Torroella, Albert; Toro, Daniel del; Alberch i Vié, Jordi, 1959-; Ginés Padrós, Silvia |
Oct-2018 | Increased levels of rictor prevent mutant huntingtin-induced neuronal degeneration | Creus Muncunill, Jordi; Rué Cabré, Laura; Alcalá Vida, Rafael; Badillos Rodríguez, Raquel; Romaní Aumedes, Joan; Marco, Sonia; Alberch i Vié, Jordi, 1959-; Pérez Otaño, Isabel; Malagelada Grau, Cristina; Pérez Navarro, Esther |
31-Oct-2011 | Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity | Xifró i Collsamata, Xavier; Anglada Huguet, Marta; Rué Cabré, Laura; Saavedra, Ana; Pérez Navarro, Esther; Alberch i Vié, Jordi, 1959- |
1-Oct-2019 | Increased translation as a novel pathogenic mechanism in Huntington's disease | Creus Muncunill, Jordi; Badillos Rodríguez, Raquel; Garcia-Forn, Marta; Masana Nadal, Mercè; García-Díaz Barriga, Gerardo; Guisado Corcoll, Anna; Alberch i Vié, Jordi, 1959-; Malagelada Grau, Cristina; Delgado García, José M.; Gruart i Massó, Agnès; Pérez Navarro, Esther |